RE: Moab. Only Astrazeneca and Eisai Inc. (so far) have had the18 Aug 2024 08:03
He also said expect to sign one maybe two before end of year . Makes hitting revenue target look virtually impossible from here . I think many are hoping not doesn't have a massive impact but I think it will maybe sub 10p even if accompanied with some news unless it's a massive deal which seems unlikely .
Still waiting to see what happened with the first AZ deal that should turn in a million plus contract of an issue to be believed in short order ,that's should be die end of October as ,6 months will be up then from when it was announced .
Even some of the bullish posters are expecting the profit warning,I expect a quite big drop on that as it's not good news . ,40-50% maybe